Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-09 5:13 pm Purchase |
2025-04-07 | 13D | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 8,735,159 18.500% |
27,994 (+0.32%) |
Filing History |
| 2025-03-07 8:22 pm Purchase |
2025-03-04 | 13D | Tenaya Therapeutics, Inc. TNYA |
Casdin Capital, LLC | 6,732,971 4.300% |
305,771 (+4.76%) |
Filing History |
| 2025-03-04 7:46 pm Purchase |
2025-02-28 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 80,864,315 21.600% |
7,098,241 (+9.62%) |
Filing History |
| 2025-02-14 4:00 pm Purchase |
2024-12-31 | 13G | Neurogene Inc. NGNE |
Casdin Capital, LLC | 1,295,361 8.700% |
270,745 (+26.42%) |
Filing History |
| 2024-11-27 6:51 pm Purchase |
2024-11-20 | 13G | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 4,592,316 5.400% |
1,380,000 (+42.96%) |
Filing History |
| 2024-11-14 4:08 pm Sale |
2024-09-30 | 13G | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,212,316 3.800% |
-1,978,190 (-38.11%) |
Filing History |
| 2024-11-08 4:33 pm Purchase |
2024-11-04 | 13G | Neurogene Inc. NGNE |
Casdin Capital, LLC | 1,024,616 6.900% |
1,024,616 (New Position) |
Filing History |
| 2024-09-26 09:27 am Purchase |
2024-09-20 | 13G | Codexis, Inc. CDXS |
Casdin Capital, LLC | 8,100,000 9.900% |
8,100,000 (New Position) |
Filing History |
| 2024-08-14 8:54 pm Purchase |
2024-08-12 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 73,766,074 19.770% |
3,364,737 (+4.78%) |
Filing History |
| 2024-06-03 5:20 pm Sale |
2024-05-30 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 70,401,337 18.910% |
-5,936,401 (-7.78%) |
Filing History |
| 2024-05-22 4:54 pm Purchase |
2024-05-17 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 76,337,738 20.370% |
1,802,072 (+2.42%) |
Filing History |
| 2024-04-18 4:36 pm Purchase |
2024-04-11 | 13G | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 5,190,506 6.080% |
1,984,126 (+61.88%) |
Filing History |
| 2024-04-08 9:03 pm Sale |
2024-02-29 | 13D | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,206,380 4.950% |
-16,560 (-0.51%) |
Filing History |
| 2024-03-20 5:25 pm Purchase |
2024-03-18 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 74,535,666 19.250% |
9,238,070 (+14.15%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 0 0.000% |
-9,220,000 (Position Closed) |
Filing History |
| 2024-02-14 4:20 pm Purchase |
2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
Casdin Capital, LLC | 7,387,943 5.990% |
1,089,369 (+17.30%) |
Filing History |
| 2024-01-09 5:13 pm Purchase |
2024-01-05 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 65,297,596 19.710% |
27,715,250 (+73.75%) |
Filing History |
| 2023-11-14 6:35 pm Sale |
2023-11-09 | 13D | EQRx, Inc. EQRX |
Casdin Capital, LLC | 0 0.000% |
-56,297,042 (Position Closed) |
Filing History |
| 2023-10-24 4:29 pm Purchase |
2023-10-19 | 13D | BioLife Solutions, Inc. BLFS |
Casdin Capital, LLC | 8,707,165 19.500% |
1,267,058 (+17.03%) |
Filing History |
| 2023-10-02 4:14 pm Purchase |
2023-09-21 | 13G | Relay Therapeutics, Inc. RLAY |
Casdin Capital, LLC | 6,298,574 5.160% |
6,298,574 (New Position) |
Filing History |